A practical breakdown of how monitors, auditors, and FDA inspectors each contribute to quality oversight, compliance, and inspection readiness across the clinical trial lifecycle Understanding Quality Oversight: Monitors vs. Auditors vs. FDA: A Quality Perspective
TThe Society of Quality Assurance Annual Meeting is a key event for quality and regulatory professionals across the life sciences industry, bringing together experts to share insights and best practices in an evolving compliance landscape.

At the SQA 2026 event, Amy Fox presented her poster, Monitors vs. Auditors vs. FDA: A Quality Perspective. The poster offers a clear, side-by-side look at how these roles differ—highlighting how monitors and auditors support quality improvement and inspection readiness, while FDA inspectors and investigators focus on regulatory enforcement and public health.

This resource is especially useful for teams looking to strengthen their understanding of compliance responsibilities and better prepare for regulatory interactions. It breaks down complex concepts into a practical, easy-to-follow format that can be applied across organizations.

At FDAQRC, we’re committed to helping clients stay ahead of regulatory expectations. From audits and inspection readiness to full lifecycle GxP support, our team delivers tailored solutions to support quality and compliance at every stage.

DISCOVER MORE